PREVALENCE AND ASSOCIATED FACTORS OF ORAL NON-CANDIDA ALBICANS CANDIDA CARRIAGE IN DENTURE WEARERS IN SANA'A CITY- YEMEN

Khaled Abdulsalam Al-Haddad1, Omar Ahmed Esma’il Al-dossary2, Hassan A. Al-Shamahy3

1Department of Orthodontic Pediatric Dentistry, Faculty of Dentistry, Sana’a University, Sana’a, Yemen

2Medical Microbiology Clinical Immunology, Faculty of Medicine Health Sciences, Sana’a University, Republic of Yemen.

3Faculty of Medicine  Heath Sciences, Sana'a University, P.O. Box 775 Sana'a, Yemen.

DOI: https://doi.org/10.22270/ujpr.v3i4.176

 

INTRODUCTION

The preponderance oral yeast infections are caused by members of the genus Candida. Candidiasis is an opportunistic infection due to pathological changes in the surface of oral mucosal cavity1,2. Candidiasis patients may show various symptoms including painful sensation, burning, swallowing difficulty change of taste, but most frequently are asymptomatic3.  The infection is generally treated with antifungal drugs, but in immune-compromised patients such as patients treated in intensive care units, cancer patients receiving radiation or chemotherapy, organ transplant patients  HIV-positive patients' return of infections may be problem. In the last twenty years, some Candida species, including C. glabrate, C. tropicalis, C. kruseiC. parapsilosis, have been isolated with increasing frequency from cases of Candidiasis4,5,6.  It is known that each species differs in the production of recognized virulence factors sensitivity to antifungal agents. Isolation identification the Candida spp. is useful in choosing correct treatment, as some species may be resistant to certain groups of antifungal   drugs7-9. Infection caused by NCAC, such as C. glabrate, C. tropicalis, C. krusei, have been found to be less response to fluconazole10.  Moreover, there are reports of numerous cases describing infection colonization of immune-compromised patients on long-term treatments of oral antifungal agents, drug resistant C. glabrate C. krusei have been recovered from them11.  As well as, host defenses have been reported to be less effective in patients infected by C. glabrata than C. albicans11. The newer triazoles, including posaconazole voriconazole; echinocandins, caspofungin, micafungin,  anidulafungin are antifungal drugs that show strong activity against Candida spp. On the other hand, echinocandins, appears to be less potent against some species, such as C. guilliermondii  C. parapsilosis8. As well, C. dubliniensis is very similar to C. albicans has been reported to have low susceptibility to azole drugs9,12.

The wearing of dentures is associated with overgrowth of Candida species, leading to denture stomatitis. Studies to identify Candida species in patients with denture stomatitis have produced contradictory results8. A number of studies assertion that a single species was responsible for the infections13 while others isolated accused multiple species of Candida14.  The objective of this study was to compare the prevalence and species colonization due to NCAC in the oral cavity of denture wearers’ non-denture wearers’ analysis associated risk factors of their colonization.

SUBJECTS LABORATORY METHODS

Subject selection

A total of two hundreds eight persons, were included in this study, 104 of them were denture wearer patients (cases group) while the other 104 adults with natural teeth (controls group), whom been selected romly from Al-Thawrah hospital, Al-Gumhory hospital Dental centers in Sana’a city, Yemen. The duration of the study was six months period, started in August 2017 ended in February 2018. Inclusion criteria for subject selection were healthy individuals with no clinical signs of Candida infection no systemic disease. In addition, individuals who smoked, currently taking antifungal, steroids, antibiotics, or immunosuppressive drugs in the past 6 months were excluded.

Collection identification of samples

Salivary samples were collected using the oral rinse technique15. In brief, each subject was asked to rinse the mouth for 60 seconds with 10 ml of sterile phosphate-buffered saline (PBS; 0.01 M phosphate-buffered saline solution, pH 7.2) expectorate the wash into a 15 ml sterile container16.  Individuals who had removable dentures were asked to take out the denture prior to samples collection. The samples were immediately transported on ice to the microbiology laboratory. Each oral rinse was centrifuged at 3500 rpm for 10 minutes, and then the supernatant was discarded. The pellet was re-suspended in 1ml sterile PBS. One hundred µl of the concentrated oral rinse was inoculated onto Sabouraudus dextrose agar incubated at 370C for 48 hours. The lasting samples were stored at -200C. If Candida colonies appeared on the Sabouraud dextrose agar, then chromogenic Candida agar was inoculated using 100 µl of the oral rinse supernatant incubated for 48 hours for colonies study.  Candida species were identified by the color of the colonies using the color reference guide supplied by the manufacturer.  When color identification was unclear, fermentation assay of sucrose, maltose, glucose, lactose galactose was done. The Candida species were also identified by the ability to produce chlamydo-spores on glutinous rice agar17.

Data analysis

Data were statistically analyzed using the EPI-Info program version 6.The difference in distribution of the Candida species between groups was based on comparison of frequency distributions by a chi-square test. A p value < 0.05 was considered significant.  

Ethical approval

We obtained written consent from all cases. Assent was taken from participants before collecting the specimens. The study proposal was evaluated and approved by the Ethics Committee of Faculty of Medicine Health Sciences, Sana'a University.

 RESULTS

There was a significant oral carriage rate of NCAC among denture wearers (cases) equaled to 38.5% comparing with only 11.1% among non-denture wearers (controls) with  OR of association equaled to 5.4 times (PV<0.001). There was a significant oral carriage rate of C. Krusei among cases (30.7%) comparing with only 7.4% in controls with 5.5 association (PV<0.001). A significant oral carriage rate of C. tropicalis among cases (15.4 %,) comparing with only 3.7% in controls with 4.7 times of association (PV=0.003), while no significant association with C. glabrata. When co-infections were considered, there was highly significant association of C. albicans + C. krusi oral colonization in cases (OR=4.56, PV<0.001), but no significant association of C. albicans + C. tropicalis infection in the denture wearer (Table 1). There was a significant oral carriage rate of NCAC species among male denture wearers (36.9%) with significant association (OR=6.6, PV?0.001). While in the females group, there was only a slightly difference between oral carriage rate of NCAC among female denture wearers comparing with non-denture wearer females. There was a highly significant association between older age groups (>45 years) of cases and contract of oral NCAC colonization with OR ranged from 1.4 to 5.4 times (table 2).  When we considered type of dental prosthesis, there was a significant rate increase with complete denture. The rate was 50%, with a highly significant association between complete denture and contract of oral NCAC colonization (OR=2.4, PV= 0.02). While no significant increase associated with colonization of NCAC with partial, acrylic /or chrome cobalt denture (table 3).

DISCUSSION

 NCAC strains, however, are isolated in growing numbers in medically compromised patients. These strains might cause systemic infections are frequently resistant to commonly used antifungal agents such as fluconazole18,19. In the present study, there was a significant oral carriage rate of NCAC among denture wearers (38.5%) comparing with only 11.1% among non-denture wearers. In addition, there was a highly significant association between denture wear and contract of oral NCAC with OR equaled to 5.4 times (PV<0.001). When single species of NCAC was considered, there was a significant oral carriage rate of C. Krusei among cases (30.7%) comparing with only 7.4% in controls with 5.5 association (PV<0.001) followed by C. tropicalis (15.4%) comparing with only 3.7% in controls with 4.7 times of association (PV=0.003), while no significant association with C. glabrata and absent of C. parapsilosis (Table 1).  Our results were different from that reported elsewhere, in which C. tropicalis was the most common NCAC, followed by C. glabrata, while C. parapsilosis were rare isolated in healthy oral colonization or as a cause of illnesses in patients.19 When co-infections were considered, there was highly significant association of C. albicans + C. krusi oral colonization in cases (OR=4.56, PV<0.001), but no significant association of C. albicans + C. tropicalis infection in the denture wearer (Table 1). The carriage rates of single  multiple Candida species were reported to be significantly higher in denture wearers.20 As it is known, NCAC may be capable of metabolizing ethanol to carcinogenic acetaldehyde  can thus progress oral  upper gastrointestinal tract cancer. So, 38.5% of our studied individuals having dentures under possible risk of oral upper gastrointestinal tract cancer. Consequently, more focus should be placed on diagnosis  treatment of oral Candida infections, also on other Candida species than C. albicans as it has been recommended19-22.

The highly significant association between denture wear  a contract of oral NCAC with the high risk (OR equaled to 5.4 times) can be explained by the fact that one of the most important virulence factors of NCAC is its ability to form biofilms, which has an important clinical consequence, as it confers resistance to antifungal therapy  capacity for yeast cells within the biofilms to resist host immune defenses.23-26 A second explanation might be due to that changes in the oral environment affected by tooth loss or denture wearing can cause changes in oral microflora.20 Also in this study, the data supported the rejection of the null hypothesis, which states that there would be no difference between male and female denture wearers in terms of the colonization by NCAC of the inner surfaces of dentures and the surrounding attachments. While there was a significant association between denture wearing in male group  a contract of oral carriage of NCAC with OR equaled to 6.6 times, (CI=2.7 -16.5, PV?0.001). Our result was different from that reported by Thein27 in which similar colonization rate was observed in both adult sexes.

Moreover, there was a trend of rising of oral NCAC colonization with increasing age in cases and controls (table 1), in which the highest rate of NCAC was in the older age groups. Our result, also, was similar to that reported by Chopde et al.28 in which extremes of age is more susceptible to oral NCAC colonization. This result can be explained by that the elderly generally suffered from systemic illnesses, changes in nourishment and their salivary characteristics28,29. Advancing age was also a risk factor for denture stomatitis in the elderly, because cell-mediated immunity, which provides protection against Candidal infection, declines with age. According to Dar-odeh  Shehabi, some oral environmental factors, such as un-stimulated salivary flow rate  age of subjects, were associated with higher numbers of microbes in the saliva of complete denture wearers30. Those authors suggested that a reduction in the salivary flow rate with aging induced an increase in concentration of microbes in saliva31.

CONCLUSION

Based on the results of this study ability of NCAC were greater in denture wearers than non-denture wearers, also greater risk of NCAC were found with males, older ages, complete denture. In addition, our results are important for the development of strategies for eliminate these indicators of risk significantly reduce NCAC colonization oral Candida infections in denture wearers.

ACKNOWLEDGMENTS

Authors acknowledge the financial support of Sana'a University, Yemen.

CONFLICT OF INTEREST

"No conflict of interest associated with this work”.

REFERENCES

  1. Gonsalves WC, Chi AC, Neville BW. Common oral lesions: Part I. Superficial mucosal lesions. Am Fam Physician. 2007; 75:501-7.
  2. Da Costa SC, De Resende MA, Lyon JP, Totti VMG, Munhoz MF. Predisposing conditions for Candida carriage in the oral cavity of denture wearers individuals with natural teeth. Can J Microbiol. 2006; 52:462-7.
  3. Samaranayake LP. Host factors oral Candidiasis. In: Mac Farlane TW, Samaranayake LP, editors. Oral cidosis. London: Butterworth and Company Ltd. 1990; 66-103.
  4. Samaranayake LP. Superficial oral fungal infections. Curr Opin Dent. 1991; 1:415-22.
  5. Scully C, El-Kabir M, Samaranayake LP. Candida oral cidosis: a review. Crit Rev Oral Biol Med. 1994; 5:125-57.
  6. Borg-von ZM, Kunz L, Rüchel R, Reichard U, Weig M, Gross U. Epidemiology antifungal susceptibilities of Candida to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. J Antimicrob Chemother. 2007; 60:424-8.
  7. Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA. In vitro susceptibility of oral Candida to seven antifungal agents. Oral Microbiol Immunol. 2005; 20:349-53.
  8. Moudgal V, Little T, Boikov D, Vazquez JA. Multiechinocin- Multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob Agents Chemother. 2005; 49:767-9.
  9. Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, et al. Comparison of the epidemiology, drug resistance mechanisms, virulence of Candida dubliniensis  Candida albicans. FEMS Yeast Res. 2004; 4:369-76.
  10. Sheehan DJ, Hitchcock CA, Sibley CM. Current emerging azole antifungal agents. Clin Microbiol Rev. 1999; 12:40-79.
  11. Mendling W, Koldovsky U. Immunological investigations in vaginal mycoses. Mycoses 1996; 39: 177-83.
  12. Schubert S, Rogers PD, Morschhäuser J. Gain of- function mutations in the transcription factor MRR1 are responsible for over expression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis Antimicrob Agents Chemother 2008; 52:4274-80.
  13. Kreher JM, Graser GN, Helman SL, Eisenberg AD. Oral yeasts, mucosal health, drug use in an elderly denture-wearing population. Spec Care Dentist. 1991; 11:222-6.
  14. Cumming CG, Wight C, Blackwell CL, Wray D. Denture stomatitis in the elderly. Oral Microbiol Immunol. 1990; 5:82-5.
  15. Coulter WA, Kinirons MJ, Murray SD. The use of a concentrated oral rinse culture technique to sample oral Candida lactobacilli in children,  the relationship between Candida  Lactobacilli levels  dental caries experience: A pilot study. Int J Paediatr Dent.1993; 3:17-21.
  16. MacFarlane TW, Samaranayake LP, Williamson MI. Comparison of Sabouraud dextrose Pagano-Levin agar media for detection  isolation of yeasts from oral samples. J Clin Microbiol. 1987; 25:162-4.
  17. Staib P, Morschhäuser J. Chlamydospore formation in Candida albicans Candida dubliniensis – an enigmatic developmental programme. Mycoses. 2007; 50:1-12.
  18. Lalla, RV; Patton, LL; Dongari-Bagtzoglou, A. Oral Candidiasis: pathogenesis, clinical presentation, diagnosis treatment strategies. J of the California Dental Association. 2013; 41 (4): 263–8.
  19. Kourkoumpetis, Themistoklis. Candida infection colonization among non-trauma emergency surgery patients. Virulence 2010; 359-366.
  20. Jenkinson HF, Douglas LJ. Interactions between Candida species bacteria in mixed infections. In: Brogden KA, Guthmiller JM, editors. Polymicrobial diseases. Washington DC: ASM Press. 2002; 357-73.
  21. Manolakaki D, Velmahos G, Kourkoumpetis T, Chang Y, Alam HB, De Moya MM, Mylonakis. Candida infection colonization among trauma patients. Virulence. 2010; 1 (5):367-375.
  22. dEnfert C; Hube B (editors). Candida: Comparative Functional Genomics. Caister Academic Press. ISBN 978-1-904455-13-4, 2007.
  23. Pereira-Cenci T, Del Bel Cury AA, Crielaard W, Ten Cate JM. Development of Candida-associated denture stomatitis: new insights. J Appl Oral Sci. 2008; 16:86-94.
  24. Coogan MM, Fidel PL Jr, Komesu MC, Maeda N, Samaranayake LP. Candida mycotic Adv Dent Res 2006; 19:130-8.
  25. Costa CR, Cohen AJ, Fernes OF, Mira KC, Passos XS, Souza LK, et al. Asymptomatic oral carriage of Candida species in HIV-infected patients in the highly active antiretroviral therapy era. Rev. Inst. Med. Trop. Sao Paulo. 2006; 48:257-61.
  26. Jin YY, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol. 2003; 41:2961-7.
  27. Thein ZM, Samaranayake YH, Samaranayake LP. In vitro biofilm formation of Candida albicans non-albicans Candida species under dynamic anaerobic conditions. Arch Oral Biol. 2007; 52:761-7.
  28. Chopde N, Jawale B, Phare A, Chaudhari L, Hiremath V, Redasani R. Microbial colonization their relation with potential cofactors in patients with denture stomatitis.  J Contemp Dent Pract. 2012; 13:456-9.
  29. Semlali A, Killer K, Alanazi H, Chmielewski W, Rouabhia M. Cigarette smoke condensate increases albicans adhesion, growth, biofilm formation, EAP1, HWP1  SAP2 gene expression. BMC Microbiol. 2014; 14:61.
  30. Dar-odeh NS, Shehabi AA. Oral Candidiasis in patients with removable dentures Mycoses. 2003; 46:187-19.
  31. Penha SS, Birman EG, Silveira FR, Paula CR. Frequency enzymatic activity (proteinase  phospholipase) of Candida albicans from edentulous patients, with  without denture stomatitis. Pesq Odontol Bras. 2000; 14:119-122.

  

Table 1: The yeast distribution in different sexes of the denture wearer (cases) non denture wearer (controls) groups of the study populations

Organisms

Cases

(No.=104)

No.         %

Controls

(No.=104 )

No.         %

OR

CI

χ2

PV

Total Non C. albicans Candida

42

38.5

12

11.5

5

2.4-10.2

35

<0.001

C. krusi

32

30.7

8

7.6

5.5

2.4-12.7

18.8

<0.001

C. tropicalis

16

15.4

4

3.8

4.7

1.5-14.6

8.4

0.003

C. glabrata

2

1.9

2

1.9

1.03

0.14-7.5

0.96

0.6

C. albicans + C. krusi

22

21.1

6

5.8

4.56

1.7-11.7

22

<0.001

C. albicans + C. tropicalis

8

7.7

4

3.8

2.16

0.6-7.4

1.9

0.16

C. albicans + C. krusi + C. tropicalis

6

5.7

0

0.0

undefined

6.5

0.012

OR- Odds ratio = Relative risk

95%CI- 95% Confidence intervals

χ 2 Chi-square = 3.9  or more is significant

pv- Probability value = 0.05 or less  is significant

 

Table 2: The carriage rate of NCAC in cases controls associated OR for different sex’s age groups

Factors

 

 

Cases

(n=104)

No.         %

Controls

(n=104 )

No.         %

OR

 

 

CI

 

 

χ2

 

 

PV

 

 

Male

36/92

39.1

8/92

8.7

6.6

2.7 -16.5

23

<0.001

Female

6/12

50

4/12

33.3

1.6

0.4-6.9

0.5

0.47

Age group

< 45 years

2/10

20

2/10

20

1.4

0.1- 10

0.0

0.97

45-54 years

8/16

50

2/16

12.5

4.4

1.0 -30

4

0.04

55 – 64 years

16/32

50

4/32

12.5

4.7

1.4-17.4

8.5

0.003

≥ 65 years

18/46

39.1

4/46

8.7

5.4

1.6-19.8

10.5

0.001

Total

42/104

40.4

12/104

11.5

5.4

2.5-11.8

23.9

<0.001

OR- Odds ratio = Relative risk

95%CI- 95% Confidence intervals

χ 2-Chi-square = 3.9  or more is significant

pv- Probability value = 0.05 or less  is significant

  

Table 3: The type of dental prosthesis factors that associated with colonization of NCAC among denture wearer patients

Factors

 

 

Positive NCAC   (n=42 )

No.                   %

OR

 

 

CI

 

 

χ2

 

 

PV

 

 

Type of dental prosthesis

Complete n=46

24

52.2

2.4

1.0.- 5.8

4.7

0.02

Partial n=58

18

31

0.4

0.16- 0.9

5.4

0.02

Acrylic n=74

30

40.5

1.02

0.4-2.6

0.00

0.97

Chrome cobalt n=38

12

31.6

0.73

0.3-1.8

0.54

0.46

OR-Odds ratio = Relative risk

95%CI-    95% Confidence intervals

χ 2-  Chi-square = 3.9  or more is significant

pv- Probability value = 0.05 or less  is significant